Reanalysis of the NCCN PD-L1 companion diagnostic assay study for lung cancer in the context of PD-L1 expression findings in triple-negative breast cancer

The companion diagnostic test for checkpoint inhibitor immune therapy is an immunohistochemical test for PD-L1. The test has been shown to be reproducible for expression in tumor cells, but not in immune cells. Immune cells were used in the IMpassion130 trial which showed PD-L1 expression was associ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Rimm, David L., Han, Gang, Taube, Janis M., Yi, Eunhee S., Bridge, Julia A., Flieder, Douglas B., Homer, Robert, Roden, Anja C., Hirsch, Fred R., Wistuba, Ignacio I., Pusztai, Lajos
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Viewpoint
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6567382/
https://ncbi.nlm.nih.gov/pubmed/31196152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-019-1156-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados